Dr. Minggui Pan
Claim this profileKaiser Permanente
Studies Solid Tumors
Studies Lung Cancer
2 reported clinical trials
2 drugs studied
Area of expertise
1Solid Tumors
RET positive
Stage IV
Stage III
2Lung Cancer
RET positive
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Minggui Pan is currently running
NB003
for Solid Cancer
This trial tests NB003, a new drug, for safety and behavior in patients with advanced cancers who have limited treatment options. It targets specific genetic changes in cancer cells to potentially stop or slow down their growth.
Recruiting1 award Phase 1
Selpercatinib
for Solid Tumors
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Recruiting1 award Phase 1 & 215 criteria
More about Minggui Pan
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Minggui Pan has experience with
- LOXO-292
- NB003
Breakdown of trials Minggui Pan has run
Lung Cancer
Thyroid Disease
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Minggui Pan specialize in?
Minggui Pan focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved RET positive patients, or patients who are Stage IV.
Is Minggui Pan currently recruiting for clinical trials?
Yes, Minggui Pan is currently recruiting for 2 clinical trials in Santa Clara California. If you're interested in participating, you should apply.
Are there any treatments that Minggui Pan has studied deeply?
Yes, Minggui Pan has studied treatments such as LOXO-292, NB003.
What is the best way to schedule an appointment with Minggui Pan?
Apply for one of the trials that Minggui Pan is conducting.
What is the office address of Minggui Pan?
The office of Minggui Pan is located at: Kaiser Permanente, Santa Clara, California 95051 United States. This is the address for their practice at the Kaiser Permanente.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.